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Summary 
Setting: National Mycobacterium Reference Laboratory, Borstel Germany. 
Objective: To evaluate the effectiveness of OMNIgene® SPUTUM reagent in comparison to a 
method using N-acetyl cysteine (NALC)-NaOH with regards to mycobacterial recovery and 
contamination of broth and solid cultures. 
Design: Sputum samples from patients with tuberculosis and other respiratory diseases 
underwent decontamination with either NALC-NaOH-based (MycoDDRTM) or OMNIgene® 
SPUTUM reagent. The decontamination procedure was assigned by block randomization. 
Samples were inoculated on Löwenstein-Jensen, Stonebrink and mycobacterial growth indicator 
tubes (MGIT). Mycobacterial recovery from samples spiked with Mycobacterium tuberculosis 
following decontamination was determined.  
Results: Eighty-five samples were randomized to NALC-NaOH and 84 to OMNIgene® 
SPUTUM reagent. Mycobacterial recovery was significantly lower for samples processed with 
OMNIgene® SPUTUM reagent vs. the NALC-NaOH method across all media types. Culture 
contamination was lower with NALC-NaOH reagent 9.4-12.9% vs. 28.6-29.8% on solid media. 
No growth was observed in MGIT among samples spiked with 10,600-16,800 CFU of M. 
tuberculosis following decontamination with OMNIgene® SPUTUM reagent. 
Conclusion: Low mycobacterial recovery, especially in MGIT, observed in this study suggests 
that OMNIgene® SPUTUM reagent might not be compatible with the MGIT system. More 
extensive field evaluations of the OMNIgene® SPUTUM reagent are warranted to demonstrate a 
significant benefit over current methods.  
Introduction 1 
Worldwide, an estimated 10.4 million new tuberculosis cases occurred in 2016; with more than a 2 
third of these cases remaining undiagnosed.1 Rapid and accurate diagnosis of tuberculosis is 3 
critical for timely initiation of treatment and, ultimately, tuberculosis control. 4 
New molecular diagnostics with sensitivities of 70-90% to detect Mycobacterium tuberculosis 5 
complex DNA in primary samples have changed the diagnostic landscape.2, 3 However, culture, 6 
using both broth and solid media, remains the standard for establishing the laboratory-based 7 
diagnosis of tuberculosis. 8 
The mycobacterial cell wall with its thick and relatively impermeable layer of mycolic acid has 9 
unique characteristics. The complexity of the cell wall represents a challenge to the organism, 10 
requiring specialized mechanisms to allow cell division to occur and resulting in prolonged 11 
generation times compared to gram-positive or -negative bacteria.4 Respiratory samples are 12 
therefore specially treated, a process called ‘decontamination’ before inoculation and incubation 13 
of broth and solid media. Decontamination and the supplementation of broth and media with 14 
antibiotics and antifungals are intended to prevent overgrowth of the slower growing 15 
mycobacteria by concomitant flora of specimens from non-sterile sites. Decontamination 16 
procedures aim at decreasing viability of gram-positive and -negative bacteria and fungi while 17 
interfering as little as possible with mycobacterial viability and growth.5  18 
Given the prolonged generation times of mycobacteria compared to other bacteria and fungi, 19 
prolonged transport at ambient temperature may result in overgrowth of contaminants even 20 
before samples have been processed.6, 7 OMNIgene® SPUTUM reagent (DNA Genotek, Ottawa, 21 
Canada) has been specifically developed to optimise the pre-analytic phase. It is a transport 22 
reagent that liquefies and decontaminates sputum while preserving viability of M. tuberculosis 23 
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for up to 8 days at temperatures as high as 40ºC. According to the product information sheet, 24 
OMNIgene® SPUTUM reagent added to sputum samples is directly compatible with all 25 
molecular tests and gold standard tuberculosis tests including smear microscopy and liquid 26 
culture (BD BACTEC™ MGIT™ 960 System, BD, Franklin Lakes, NJ, USA) and the Xpert® 27 
MTB/RIF assay (Cepheid, Sunnyvale, CA, USA).8, 9  28 
This study aimed to evaluate the effectiveness of OMNIgene® SPUTUM reagent with regards to 29 
mycobacterial recovery and contamination of broth and solid cultures versus a commercially 30 
available CE-marked N-acetyl cysteine (NALC)-NaOH method using sputum samples submitted 31 
by patients treated for tuberculosis or admitted for the management of other pulmonary diseases. 32 
 33 
Methods:  34 
Sputum samples 35 
Over a period of 10 weeks (August-October 2016) patients admitted to the chest hospital in 36 
Borstel submitted sputum samples on two days of the week; samples were processed on the day 37 
of collection by the National Mycobacterium Reference Laboratory. The method used for 38 
decontamination was assigned by block randomization with the unit of randomization being the 39 
day of the week. 40 
 41 
Decontamination procedures 42 
Samples were either processed using a CE-marked NALC-NaOH method (MycoDDRTM, 43 
IMMY, Norman, USA)10 or OMNIgene® SPUTUM reagent (DNA Genotek, Ottawa, Canada)9 44 
according to the manufacturer’s instructions at the time of the study. In brief for the NALC-45 
NaOH method equal volumes of detergent (2.5% NaOH reagent) were added 1:1 to samples 46 
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measuring up to 10 ml, samples were split if the volume was >10ml.  Samples were incubated 47 
for 15 min at room temperature and vortexed every 5 min for 30 sec. Kit-specific neutralisation 48 
buffer was added until a colour change indicated a neutral pH, followed by 15 min centrifugation 49 
at 3000 x g at 8°C. Supernatants were discarded and pellets re-suspended in kit-specific 50 
resuspension buffer to achieve a final volume of 2 ml. The OMNIgene® SPUTUM reagent was 51 
added in equal volume to each sample. Samples were incubated for 20 min at room temperature 52 
with intermittent vortexing every 5 min, followed by 15 min centrifugation at 3800 g at room 53 
temperature. Supernatants were removed and pellets suspended in sterile water aiming for a final 54 
volume of 2 ml.  Before inoculation pH-values were measured using a pH test paper (ChemoLine 55 
GmbH, Hennef, Germany).  56 
 57 
Mycobacterial culture 58 
Following decontamination 100 μl of the resuspended pellet were inoculated on Löwenstein-59 
Jensen (LJ) and Stonebrink slants (Artelt-ENCLIT GmbH, Wyhra, Germany) supplemented with 60 
antimicrobial drugs (polymyxin B, amphotericin B, carbenicillin, and trimethoprim [PACT]). In 61 
addition, 500 μl of the resuspended pellet were inoculated in mycobacterial growth indicator 62 
tubes (MGIT, Becton Dickinson, Heidelberg, Germany) supplemented with an antimicrobial 63 
mixture containing polymyxin B, amphotericin B, nalidixic acid, trimethoprim, and azlocillin 64 
(PANTA) and incubated at 37º for a maximum of 42 days. Solid media were reviewed weekly 65 
for growth of mycobacteria for a total of 8 weeks. Contamination and mycobacterial recovery 66 
rates were calculated stratified by media and decontamination method. In addition, time to 67 
positivity in days was determined for broth (MGIT). For positive MGITs an aliquot of 1 ml was 68 
taken from the bottom of the tube, centrifuged for 10 min at 3600 x g and the supernatant 69 
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discarded. 10 μl of the pellet were used to prepare a microscopy slide. Following heat fixation, 70 
Kinyoun staining was performed to determine the presence of acid fast bacilli or other bacteria. 71 
The remaining pellet was resupended in 500 μl of NaCl, 50 μl were inoculated on Columbia 72 
blood agar (Beckton Dickinson, Heidelberg, Germany) and incubated at 37 C for 24 hours.  A 73 
positive MGIT was classified as contaminated if no acid-fast bacilli were seen on microscopy 74 
and other non-acid-fast bacteria were present on microscopy and/or on blood agar. Identification 75 
of mycobacteria was performed using the Genotype HAIN CM or TBC (HAIN Lifescience, 76 
Nehren, Germany) as per the manufacturers’ instructions.  77 
 78 
Spiked samples 79 
A suspension of 1.5% methylcellulose (Sigma-Aldrich, Germany) was spiked with M. 80 
tuberculosis H37Rv aiming for a final concentration of 10,000-20,000 colony-forming units 81 
(CFU)/ml. 100 μl of the undiluted suspension and serial dilutions (1 in 10, and 1 in 100) were 82 
inoculated in  83 
7H10 agar plates in duplicates and incubated at 37ºC for 4 weeks. CFU were determined by 84 
calculating the mean of all six 7H10 agar plates taking the dilution into account. 85 
To determine the effect of NALC-NaOH decontamination and OMNIgene® SPUTUM reagent 86 
on viability of mycobacteria 2 ml of the bacterial suspension underwent processing with NALC-87 
NAOH or OMNIgene® SPUTUM reagent prior to inoculation. The bacterial suspension without 88 
any pre-treatment served as a growth control.  89 
LJ and Stonebrink slopes were inoculated with 100 μl, while MGIT were inoculated with 500 μl 90 
resuspended sediment (or the untreated bacterial suspension). Samples were set up in duplicate 91 
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and experiments were repeated on two different days (experiment I and II). Cultures on solid 92 
media were checked weekly for mycobacterial growth.  93 
 94 
Statistical analysis 95 
Collected data were entered in an Excel database (Microsoft Office). Statistical analysis was 96 
performed using Stata version 14 (Stata-Corp, TX, USA). We compared the proportion of 97 
contaminated cultures using the NALC-NaOH method as a reference. The χ2 was used to 98 
evaluate differences in proportions.  The Wilcoxon Rank sum test was used to compare medians. 99 
The level of significance was set at α=0.05. 100 
 101 
Ethics 102 
Individual patient consent was obtained. The study was approved by the Ethical Committee of 103 
the University of Lübeck, Germany (#16-209). 104 
 105 
Results 106 
A total of 169 samples from 34 patients were included in the study, 85 samples were randomized 107 
to NALC-NaOH and 84 to OMNIgene® SPUTUM reagent. Most samples were submitted by 108 
patients on treatment for drug susceptible tuberculosis (n=82) and multi-drug resistant 109 
tuberculosis (n=74). There was no difference in sample distribution across methods (figure 1, 110 
p<0.01). 111 
The proportion of samples revealing growth of M. tuberculosis was significantly lower for 112 
samples processed using the OMNIgene® SPUTUM reagent compared to samples processed 113 
with the NALC-NaOH method across all media (table 1). In the MGIT system only 6 (7.1%) 114 
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samples grew M. tuberculosis following treatment with OMNIgene® SPUTUM reagent 115 
compared to 17 (20%) when using the NALC-NaOH method. Median time to positivity was 9.5 116 
days for the NALC-NaOH method and 13.9 days for OMNIgene® SPUTUM reagent. In the 117 
OMNIgene® SPUTUM reagent group more than a quarter of samples inoculated on LJ or 118 
Stonebrink were contaminated compared to 9.4-12.9% in the NALC-NaOH group. In contrast 119 
only 7.1% of samples processed using OMNIgene® SPUTUM reagent were contaminated in the 120 
MGIT compared to 20% of samples in the NALC-NaOH group. The median pH of the 121 
resuspended pellet was neutral (7) for samples treated with NALC-NaOH compared to 8.5 for 122 
samples undergoing the OMNIgene® SPUTUM reagent method.  123 
Spiked samples had a mean of 16,800 CFU of M tuberculosis per ml in the first experiment and 124 
10,600 CFU in the second experiment. The mean (average of the duplicate samples) time to 125 
culture positivity was 8.2 and 9.6 days for the growth control tubes and 11.5 and 12.0 days for 126 
suspensions treated with NALC-NaOH. No growth was recorded for suspensions treated with 127 
OMNIgene® SPUTUM reagent after 6 weeks of incubation. On solid media growth of M. 128 
tuberculosis was observed in samples undergoing either method (OMNIgene® SPUTUM reagent 129 
or NALC-NaOH), albeit growth was reduced for samples treated with OMNIgene® SPUTUM 130 
reagent. 131 
 132 
Discussion 133 
This study found that samples decontaminated using OMNIgene® SPUTUM reagent had lower 134 
mycobacterial recovery than those processed using the NALC-NaOH-based method. 135 
Contamination rates on solid media were higher in samples treated with OMNIgene® SPUTUM 136 
reagent compared to NALC-NaOH. 137 
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According to the manufacturer, the OMNIgene® SPUTUM reagent is compatible with both solid 138 
media and MGIT. However, in this study we found significantly decreased mycobacterial 139 
recovery both on solid media and in MGIT when samples were processed using OMNIgene® 140 
SPUTUM reagent. For solid media, the increase in culture contamination might have directly 141 
impaired mycobacterial recovery due to overgrowth of the contaminant organisms. Time to 142 
culture positivity in MGIT appeared to be longer, although the number of positive samples was 143 
low. Furthermore, mycobacteria could not be recovered from broth using samples spiked with M. 144 
tuberculosis. Other studies have also found an increase in time to positivity when using 145 
OMNIgene® SPUTUM reagent in combination with the MGIT system.11, 12 This might suggest 146 
that one or more of the components of the OMNIgene® SPUTUM reagent might interfere with 147 
components in the MGIT or directly with mycobacterial growth. While the exact components of 148 
OMNIgene® SPUTUM reagent are unknown, the product safety data sheet lists sodium dodecyl 149 
sulphate (SDS) 1-5%.13 It is well established the SDS is not compatible with the MGIT system 150 
due to its strong binding to proteins present in the medium which can in turn impair 151 
mycobacterial growth (and possibly that of other bacteria).14 This would result in both poor 152 
recovery and delayed time to detection, but also in relatively low “contamination rates”. Another 153 
explanation of the low proportion of positive cultures across all media is the alkali pH following 154 
re-suspension. A high pH may cause injury or death to mycobacteria and delayed mycobacterial 155 
revival resulting in growth delays.15  156 
The results of this study are in contrast with a study conducted in Nepal showing increased 157 
mycobacterial detection and decreased culture contamination in samples processed using the 158 
OMNIgene® SPUTUM reagent. However, cultures were performed on solid media only and 159 
incubation time of sputum samples with OMNIgene® SPUTUM reagent was prolonged (up to 8 160 
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days) rather than 20 min.16 Length of incubation might influence performance of OMNIgene® 161 
SPUTUM reagent. A study from Uganda reported lower proportions of positive cultures among 162 
samples processed on the day of collection using OMNIgene® SPUTUM reagent compared to 163 
NALC-NaOH, albeit the number of same-day processed samples was low.12 However, across all 164 
incubation durations, the number of samples revealing mycobacterial growth was lower in the 165 
OMNIgene® SPUTUM reagent group compared to the standard of care.12  166 
Recently, Genotek changed the OMNIgene® SPUTUM reagent sample processing instructions. 167 
The minimum incubation time was increased from 20 to 30 min. The instructions now 168 
recommend adding phosphate-buffered saline (PBS) to the mix of sputum samples and 169 
OMNIgene® SPUTUM reagent before centrifugation. Generally longer incubation times might 170 
be beneficial, while adding PBS might result in diluting some of the SDS, and the pH might get 171 
closer to neutrality.  172 
Our study did not show any benefit of OMNIgene® SPUTUM reagent over NALC-NaOH with 173 
regards to contamination. This is in contrast with the findings from other studies reporting lower 174 
culture contamination rates when using OMNIgene® SPUTUM reagent.12, 16 The difference 175 
might be explained by differences in patient populations. The majority of patients submitting 176 
sputum samples for this study were on treatment for drug susceptible or resistant tuberculosis 177 
and hence contamination rates were particularly high. The studies from Nepal and Uganda only 178 
included patients who had symptoms suggestive of tuberculosis, but were not yet on treatment.  179 
The strengths of this study are its cluster randomized design, the use of a challenging patient 180 
population and the combined approach of using both patient samples and spiked samples. The 181 
study is limited by its small sample size and the low number of positive samples.  182 
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In conclusion, this study suggests that OMNIgene® SPUTUM reagent might not be compatible 183 
with the MGIT system. This is supported by the lower proportion of positive cultures across 184 
solid culture and broth and the prolonged time to culture positivity. Rigorous field evaluations of 185 
the OMNIgene® SPUTUM reagent are needed to demonstrate a significant benefit over currently 186 
used methods.  187 
 188 
Acknowledgements: We are grateful to all the laboratory staff at the National Mycobacterium 189 
Reference Laboratory who processed the samples and to the patients who participated in the 190 
study. We also would like to acknowledge Dr Jan Heyckendorf who supported enrolment of 191 
patients.  192 
 193 
Conflict of interest: Kits for decontamination were provided free of charge from the 194 
manufacturers. None of the companies had any influence on the results of the study.  195 
12 
 
Table 1. Contamination and mycobacterial recovery 
 
Result 
NALC-NaOH MycoDDRTM 
N=85 
N (%) 
OMNIgene® 
N=84 
N (%) 
P value 
Löwenstein-Jensen 
Growth of M. tuberculosis 18 (21.2%) 13 (15.5%) 
0.006 Contamination 8 (9.4%) 24 (28.6%) 
No growth 59 (69.4%) 47 (56.0%) 
Stonebrink 
Growth of M. tuberculosis 18 (21.2%) 14 (16.7%) 
0.028 Contamination 11 (12.9%) 25 (29.8%) 
No growth 56 (67.9%) 45 (54.6%) 
Mycobacterial Growth 
Indicator Tubes 
Growth of M. tuberculosis 17 (20.0%) 6 (7.1%) 
0.001 Contamination 17 (20%) 6 (7.1%) 
No growth 51 (60.0%) 72 (85.7%) 
pH of the resuspended pellet, median (interquartile range) 7 (6.75; 7) 8.5 (8; 8.5) 0.001 
  
 
  
13 
 
Figure 1. Method used for decontamination according to diagnosis. 
 
Each pair of bars represents an individual patient; black bars show samples processed using 
MycoDDRTM while light bars show samples processed using OMNIgene® SPUTUM reagent. 
DS= drug-susceptible; TB = tuberculosis, MDR = multidrug resistant 
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